This is the Impact Registry February of 2023 case scenario where we will focus on inclusion criteria. A 38-year-old female presents to the emergency department with complaints of sudden onset of left arm numbness and weakness, left-sided facial droop, difficulty speaking, and headache, along with visual changes. She has a strong family history for CAD. Her father had an MI at age 50. The patient has a history of migraine headaches, which she controls with over-the-counter medication, and reports her current symptoms are different from a migraine headache. Her neurological exam reveals mild expressive dysphagia, left upper extremity weakness, and impaired finger-nose coordination on the left side. ECG shows a sinus rhythm and labs are within normal limits. A STAT head CT is performed and is negative for an ischemic stroke. However, due to her current symptoms, a transthoracic echocardiogram is performed, and the patient is diagnosed with a patent foramen ovale. Because of the patient's age and risk for strokes, she is taken to the cath lab for PFO closure for stroke prevention. Our question, does this patient meet the general submission population? Number one, no, or number two, yes. Please take a few moments to review the documentation in question before determining the best answer. And the answer is no. The patient was not diagnosed with a congenital cardiac defect in the given scenario. While a patent foramen ovale and an atrial septal defect are both holes between the right atrium and left atrium, they are not the same, nor should the terms be used interchangeably. A patent foramen ovale can only occur after birth when the foramen ovale fails to close after the newborn takes its first breath. An atrial septal defect is a failure of the septal tissue to form between the right atria and left atria, and is something an individual is born with. Thank you for viewing the IMPACT Registry Case Scenario for February of 2023, where we discussed inclusion criteria.

inclusion criteria

coronary artery disease

PFO closure

stroke prevention

atrial septal defect